I agree it seems on the surface like a mutually beneficial PR stunt, which would be pathetically shallow.
On the other hand, this could be YC's foot in the door to disrupt the high margin, high investment, treatment over cure model of the health industry, in which case more power to them. We can expect to see YC spinning off a health division. That seems like quite the challenge - hope they know what they are getting themselves into.
We do need more altruism in the health research market that will bring unpatentable cures to market instead of expensive long term treatments.
On the other hand, this could be YC's foot in the door to disrupt the high margin, high investment, treatment over cure model of the health industry, in which case more power to them. We can expect to see YC spinning off a health division. That seems like quite the challenge - hope they know what they are getting themselves into.
We do need more altruism in the health research market that will bring unpatentable cures to market instead of expensive long term treatments.